Exact Sciences Corporation (BMV:EXAS)

Exact Sciences Statistics

Total Valuation

Exact Sciences has a market cap or net worth of MXN 185.50 billion. The enterprise value is 216.35 billion.

Market Cap	185.50B
Enterprise Value	216.35B

Important Dates

The next estimated earnings date is Monday, November 3, 2025.

Earnings Date	Nov 3, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	188.64M
Shares Outstanding	n/a
Shares Change (YoY)	+2.39%
Shares Change (QoQ)	+1.12%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	187.46M

Valuation Ratios

PE Ratio	n/a
Forward PE	66.07
PS Ratio	3.35
PB Ratio	3.98
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 99.58, with an EV/FCF ratio of 67.64.

EV / Earnings	-11.41
EV / Sales	4.00
EV / EBITDA	99.58
EV / EBIT	n/a
EV / FCF	67.64

Financial Position

The company has a current ratio of 2.89, with a Debt / Equity ratio of 1.03.

Current Ratio	2.89
Quick Ratio	2.38
Debt / Equity	1.03
Debt / EBITDA	21.46
Debt / FCF	14.96
Interest Coverage	-4.84

Financial Efficiency

Return on equity (ROE) is -35.51% and return on invested capital (ROIC) is -1.58%.

Return on Equity (ROE)	-35.51%
Return on Assets (ROA)	-1.39%
Return on Invested Capital (ROIC)	-1.58%
Return on Capital Employed (ROCE)	-2.63%
Revenue Per Employee	7.98M
Profits Per Employee	-2.73M
Employee Count	7,000
Asset Turnover	0.47
Inventory Turnover	5.97

Taxes

Income Tax	-173.89M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +2.08% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+2.08%
50-Day Moving Average	n/a
200-Day Moving Average	n/a
Relative Strength Index (RSI)	39.66
Average Volume (20 Days)	442

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.34

Income Statement

In the last 12 months, Exact Sciences had revenue of MXN 55.44 billion and -18.96 billion in losses. Loss per share was -101.75.

Revenue	55.44B
Gross Profit	38.60B
Operating Income	-2.62B
Pretax Income	-19.13B
Net Income	-18.96B
EBITDA	1.48B
EBIT	-2.62B
Loss Per Share	-101.75

Balance Sheet

The company has 16.19 billion in cash and 47.84 billion in debt, giving a net cash position of -31.65 billion.

Cash & Cash Equivalents	16.19B
Total Debt	47.84B
Net Cash	-31.65B
Net Cash Per Share	n/a
Equity (Book Value)	46.57B
Book Value Per Share	246.11
Working Capital	18.59B

Cash Flow

In the last 12 months, operating cash flow was 5.76 billion and capital expenditures -2.56 billion, giving a free cash flow of 3.20 billion.

Operating Cash Flow	5.76B
Capital Expenditures	-2.56B
Free Cash Flow	3.20B
FCF Per Share	n/a

Margins

Gross margin is 69.63%, with operating and profit margins of -4.73% and -34.19%.

Gross Margin	69.63%
Operating Margin	-4.73%
Pretax Margin	-34.51%
Profit Margin	-34.19%
EBITDA Margin	2.66%
EBIT Margin	-4.73%
FCF Margin	5.77%

Dividends & Yields

Exact Sciences does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-2.39%
Shareholder Yield	n/a
Earnings Yield	-10.22%
FCF Yield	1.72%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Exact Sciences has an Altman Z-Score of 1.37 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.37
Piotroski F-Score	5